DRUG · Mapped RxNorm record
docetaxel
Normalized identity: docetaxelView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
NCT00430183
Drugs and interventions used in this trial
3 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
LHRH agonist
Find medicine records ·
Find other trials using this name
PROCEDURE · Unmapped registry intervention
surgery
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedSurgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
Design: INTERVENTIONAL · Status: ACTIVE NOT RECRUITING · Phase: PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Prostate Cancerverified · MONDO: prostate cancer
Interventions
Sponsors & collaborators
Alliance for Clinical Trials in Oncologylead sponsor
National Cancer Institute (NCI)collaborator
Eastern Cooperative Oncology Groupcollaborator
NCIC Clinical Trials Groupcollaborator
SWOG Cancer Research Networkcollaborator
Mapped research locations
HonoluluHawaii, United States6OmahaNebraska, United States5TacomaWashington, United States5Kansas CityMissouri, United States4BillingsMontana, United States4SeattleWashington, United States3MinneapolisMinnesota, United States3AlbuquerqueNew Mexico, United States3ChicagoIllinois, United States2PhiladelphiaPennsylvania, United States2DenverColorado, United States2Ann ArborMichigan, United States2
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00430183 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.